1- Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran
2- Rajaei Clinical Research Development Unit,Alborz University of Medical Sciences, Karaj, Iran
Abstract: (250 Views)
In March 2020, the World Health Organization (WHO) announced that the disease caused by the SARS-COV-2 virus (COVID-19) is a pandemic. The initial symptoms of COVID-19 typically include fever, dry cough, and fatigue. Although cerebrovascular symptoms and strokes have also been mentioned as complications of COVID-19, the exact pathophysiology of these conditions is still not fully understood, and the route of virus entry into the nervous system remains unclear, with various hypotheses proposed. Regarding brain hemorrhage and its connection to COVID-19, a study raised the question of whether COVID-19 is the cause of this complication or merely a coincidence. It has been hypothesized that the angiotensin-converting enzyme 2 (ACE2) receptor, present in the endothelial cells of cerebral vessels and involved in vascular autoregulation and cerebral blood flow, may be affected by COVID-19, potentially leading to disturbances in cerebral autoregulation and ultimately resulting in the rupture of cerebral vessels. This case report presents a 76-year-old man with brain hemorrhage and concurrent COVID-19, confirmed by PCR testing.
Type of Study:
Case Report |
Subject:
Special Received: 2020/10/21 | Accepted: 2022/09/12 | Published: 2024/11/30